Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain

European Journal of Pain

Volumn 11, Issue 3, 2007, Pages 329-340

  Rejas, Javier ^a   Ribera, María Victoria ^b   Ruiz, Manuel ^a   Masrramón, Xavier ^c  

^a PFIZER INC   (United States)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Euroclin   (Spain)

Author keywords

Minimal important difference; MOS Sleep Scale; Neuropathic pain; Psychometric properties; Sensitivity; Usual care; Validity

Indexed keywords

GABAPENTIN;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL TRIAL; DEPRESSION; DISABILITY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL OUTCOMES STUDY SLEEP SCALE; NEUROPATHIC PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; TREATMENT DURATION; VALIDITY;

ADULT; AGED; AMINES; ANALGESICS; ANXIETY; CYCLOHEXANECARBOXYLIC ACIDS; DEPRESSION; DISABILITY EVALUATION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PAIN MEASUREMENT; PAIN, INTRACTABLE; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PSYCHOMETRICS; SLEEP DISORDERS;

EID: 33846807688     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2006.05.002     Document Type: Article

References (41)

1. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., and Hes M. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280 (1998) 1831-1836
2. Badía X. La medida de la calidad de vida relacionada con la salud en los ensayos clínicos. In: Sacristán J.A., Badía X., and Rovira J. (Eds). En: Farmacoeconomía: Evaluación Económica de Medicamentos (1995), Editores Médicos, Madrid 51-76
3. Bowsher D. Neurogenic pain syndromes and their management. Br Med Bull 47 (1991) 644-666
4. Buysse D.J., Reynolds III C.F., Monk T.H., Berman S.R., and Kupfer D.J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiat Res 28 (1989) 193-213
5. Chassany O., Sagnier P., Marquis P., Fullerton S., Aaronson N., and for the European Regulatory Issues on Quality of Life Assessment Group. Patient-reported outcomes: the example of health-related quality of life - a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf J 36 (2002) 209-238
6. Coyne K.S., Zhou Z., Bhattacharyya S.K., Thompson S.L., Dhawan R., and Versi E. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int 9 (2003) 948-954
7. Fayers P.M., and Machin D. Quality of life. Assessment, analysis and interpretation (2000), Wiley, Chichester
8. Foldvary-Schaefer N., De Leon Sanchez I., Karafa M., Mascha E., Dinner D., and Morris H.H. Gabapentin increases slow-wave sleep in normal adults. Epilepsia 43 (2002) 1493-1497
9. Gálvez R, and the Spanish team for Study of Neuropathic Pain. Pharmacoepidemiologic and multidisciplinary study of gabapentin in neuropathic pain [abstract]. Neuropathic Pain. Changing paradigms in diagnosis and treatment. An International Congress of NeuPSIG. Madrid; 2004.
10. Gandek B., Ware J., Aaronson N., Apolone G., Bjorner J., Brazier J., et al. Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: result from the IQUOLA project. J Clin Epidemiol 51 (1998) 1171-1178
11. Gureje O., Von Korff M., Simon G.E., and Gater R. Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA 280 (1998) 147-151
12. Guyat G.H., Osoba D., Wu A.W., Wyrwich K.W., Norman G.R., and and the clinical significance consensus meeting group. Methods to explain the clinical significance of Health Status Measures. Mayo Clin Proc 77 (2002) 371-383
13. Guyatt G.H., Feeny D.H., and Patrick D.L. Measuring health-related quality of life. Ann Inter Med 118 (1993) 622-629
14. Harris S., Morley S., and Barton S.B. Role loss and emotional adjustment in chronic pain. Pain 105 (2003) 363-370
15. Hays R.D., and Stewart A.L. Sleep measures. In: Stewart A.L., and Ware J.E. (Eds). Measuring functioning and well-being: the Medical Outcomes Study approach (1992), Duke University Press, Durham (NC) 235-259
16. Hays R.D., and Woolley J.M. The concept of clinically meaningful difference in health-related quality of life research. Pharmacoeconomics 18 (2000) 419-423
17. Hays R.D., Martin S.A., Sesti A.M., and Spritzer K.L. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med Rev 6 (2005) 41-44
18. Higginson I.J., and Carr A.J. Using quality of life measures in the clinical setting. BMJ 322 (2001) 1297-1300
19. Jaeschke R., Singer J., and Guyatt G.H. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 10 (1989) 407-415
20. Jensen P.G., and Larson J.R. Management of painful diabetic neuropathy. Drugs Aging 18 (2001) 737
21. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991) 540-545
22. Juniper E.F., Guyatt G.H., Willan A., and Griffith L.E. Determining a minimal important change in a disease - specific quality of life questionnaire. J Clin Epidemiol 47 (1994) 81-87
23. Katz J.N., Larson M.G., Phillips C.B., Fossel A.H., and Liang M.H. Comparative measurement sensitivity of short and longer health status instruments. Med Care 30 (1992) 917-925
24. Kazis L.E., Anderson J.J., and Meenan R.F. Effect sizes for interpreting changes in health status. Med Care 27 (1989) S178-S189
25. Lesser H., Sharma U., LaMoreaux L., and Poole R.M. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 63 (2004) 2104-2110
26. Lipman R.S. Differentiating anxiety and depression in anxiety disorders: use of rating scales. Psychol Bull 18 (1982) 69-77
27. Lipman R.S., and Covi L. Outpatient treatment of neurotic depression: medication and group psychotherapy. In: Spitzer R., and Klein D. (Eds). Evaluation of psychological therapies (1976), Johns Hopkins University Press, Baltimore (MD) 178-218
28. Manocchia M., Keller S., and Ware J.E. Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill. Qual Life Res 4 (2001) 331-345
29. Marquis P. Sleep disturbance: a component of health status. Pharmacoeconomics 10 (1996) S25-S28
30. McWilliams L.A., Cox B.J., and Enns M.W. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain 106 (2003) 127-133
31. Melzack R. The short-form McGill Pain Questionnaire. Pain 30 (1987) 191-197
32. IASP Task Force in Taxonomy. Pain terms: a current list with definitions and notes on usage. In: Merksey H., and Bogduk N. (Eds). Classification of chronic pain syndromes and definitions of pain terms. 2nd ed. (1994), IASP Press, Washington (DC) 206-213
33. Nicholson B., and Verma S. Comorbidities in chronic neuropathic pain. Pain Med 5 (2004) S9-S27
34. Nunnally J., and Bernstein I. Psychometric theory (1994), McGraw-Hill, New York
35. Raskin A., Schulterbrandt J., Reating N., and McKeon J.J. Replication of factors of psychopathology in interview, ward behaviour and self report ratings of hospitalized depressives. J Nerv Ment Dis 148 (1969) 87-98
36. Rosenstock J., Tuchman M., LaMoreaux L., and Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double blind, placebo-controlled trial. Pain 110 (2004) 628-638
37. Rowbotham M., Harden N., Stacey B., Bernstein P., and Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280 (1998) 1837-1842
38. Sheehan D.V., Harnett-Sheehan K., and Raj B.A. The measurement of disability. Int Clin Psychopharmacol 11 (1996) S89-S95
39. Sloan J.A., Cella D., Frost M., Guyatt G.H., Sprangers M., Symonds T., and and the clinical significance consensus meeting group. Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc 77 (2002) 367-370
40. Smith T.E., and Chong M.S. Neuropathic pain. Hosp Med 6 (2000) 760-766
41. Stewart A.L., Greenfield S., Hays R.D., Wells K., Rogers W.H., Berry S.D., et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 262 (1989) 907-913